The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
Abstract
Few medicines are awaited as eagerly as COVID-19 vaccines. Extraordinary efforts by scientists, regulators, and developers enabled the European Medicines Agency (EMA) to recommend the first EU conditional marketing authorisation (CMA) for the BioNTech COVID-19 mRNA vaccine (nucleoside-modified) BNT162b2 (Comirnaty)1European Medicines AgencyComirnaty assessment...
Paper Details
Title
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
Published Date
Jan 1, 2021
Journal
Volume
397
Issue
10272
Pages
355 - 357
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History